LYNGBY, Denmark--(BUSINESS WIRE)--Today, Intomics A/S and LEO Pharma A/S announced a collaboration under which LEO Pharma gains access to Intomics’ unique biological data analysis expertises. The recently founded spin-off company from The Danish Technical University, Intomics, has methods and tools for use in LEO Pharma’s early drug discovery. The collaboration spans a range of research projects. The financial terms of the agreement were not disclosed.
